Skip to content

Narcotic Control Regulations

C.R.C., c. 1041

In forceCurrent to September 30, 2026 HistoryMade under: Controlled Drugs and Substances Act

Loading…

ss. 25.3 to 74

Licensed Dealers

Sale of Narcotics

Marginal note:Provision to hospital employee

  •  (1) Subject to subsection (2), a licensed dealer may provide a narcotic to a hospital employee.

  • Marginal note:Exception — heroin

    (2) A licensed dealer may provide diacetylmorphine (heroin) to a hospital employee only if that hospital provides care or treatment to persons.

  • SOR/2019-169, s. 3
.

Marginal note:Sale to exempted person

 A licensed dealer may sell or provide a narcotic to a person who is exempted under section 56 of the Act with respect to the possession of that narcotic.

  • SOR/2019-169, s. 3
.

Marginal note:Sale to Minister

 A licensed dealer may sell or provide a narcotic to the Minister.

  • SOR/2019-169, s. 3
.

Marginal note:Written order

 A licensed dealer may sell or provide a narcotic under any of sections 25 to 25.5 if

  • (a) the dealer has received a written order that specifies the name and quantity of the narcotic to be supplied and is signed and dated

    • (i) in the case of a narcotic to be provided to a hospital employee or a practitioner in a hospital, by the pharmacist in charge of the hospital’s pharmacy or by a practitioner authorized by the person in charge of the hospital to sign the order, and

    • (ii) in any other case, by the person to whom the narcotic is to be sold or provided; and

  • (b) the dealer has verified the signature, if it is unknown to them.

  • SOR/2019-169, s. 3
.

Marginal note:Verbal order

  •  (1) A licensed dealer may sell or provide a verbal prescription narcotic under sections 25 to 25.5 if

    • (a) the dealer has received a verbal order that specifies the name and quantity of the narcotic to be supplied; and

    • (b) in the case of the provision of the narcotic to a hospital employee or a practitioner in a hospital, the order has been placed by the pharmacist in charge of the hospital’s pharmacy or by a practitioner authorized by the person in charge of the hospital to place the order.

  • Marginal note:Receipt

    (2) A licensed dealer that receives a verbal order from a pharmacist or practitioner must, within five working days after filling the order, obtain and keep a receipt that includes

    • (a) the signature of the pharmacist or practitioner who received the narcotic;

    • (b) the date on which the pharmacist or practitioner received the narcotic; and

    • (c) the name and quantity of the narcotic.

  • Marginal note:No further sale without receipt

    (3) If the licensed dealer has not obtained the receipt within five working days, the dealer must not sell or provide a narcotic to the pharmacist or practitioner in accordance with a further verbal order received from them until after obtaining the receipt.

  • SOR/2019-169, s. 3
.

Packaging and Transportation

Marginal note:Packaging — sale and provision

  •  (1) A licensed dealer that sells or provides a narcotic, other than a preparation described in section 36, must securely package it in its immediate container, which must be sealed in such a manner that the container cannot be opened without breaking the seal.

  • Marginal note:Packaging — transport and export

    (2) A licensed dealer that transports or exports a narcotic must ensure that its package is sealed in such a manner that the package cannot be opened without breaking the seal.

  • Marginal note:Exception

    (3) Subsection (1) does not apply to a test kit that contains a narcotic and that has a registration number.

  • SOR/2003-134, s. 2
  • SOR/2019-169, s. 3
.

Marginal note:Transport

  •  (1) A licensed dealer must, in taking delivery of a narcotic that they have imported or in making delivery of a narcotic,

    • (a) take any measures that are necessary to ensure the security of the narcotic while it is being transported;

    • (b) subject to subsection (2), use a method of transportation that permits an accurate record to be kept of all handling of the narcotic as well as of the signatures of every person handling the narcotic until it is delivered to the consignee;

    • (c) in the case of an imported narcotic, transport it directly to the site specified in their licence after it is released under the Customs Act; and

    • (d) in the case of a narcotic that is to be exported, transport it directly from the site specified in their licence to the customs office where it will be exported.

  • Marginal note:Exception

    (2) A licensed dealer may have a verbal prescription narcotic transported by a common carrier.

  • SOR/2019-169, s. 3
.

Thefts, Losses and Suspicious Transactions

Marginal note:Protective measures

 A licensed dealer must take any measures that are necessary to ensure the security of any narcotic in their possession and any licence or permit in their possession.

  • SOR/78-154, s. 4
  • SOR/85-588, s. 7
  • SOR/85-930, s. 5
  • SOR/99-124, s. 3
  • SOR/2004-237, s. 12
  • SOR/2010-221, s. 12
  • SOR/2012-230, s. 19
  • SOR/2013-119, s. 210
  • SOR/2013-172, s. 6
  • SOR/2014-260, ss. 23(E), 26(F)
  • SOR/2016-239, s. 5
  • SOR/2018-37, s. 3
  • SOR/2018-147, s. 10
  • SOR/2019-169, s. 3
.

Marginal note:Theft or loss — licences and permits

 A licensed dealer that becomes aware of a theft or loss of their licence or permit must provide a written report to the Minister within 72 hours after becoming aware of it.

  • SOR/2019-169, s. 3
.

Marginal note:Theft or unexplainable loss — narcotics

 A licensed dealer that becomes aware of a theft of a narcotic or of a loss of a narcotic that cannot be explained on the basis of normally accepted business activities must

  • (a) provide a written report to a member of a police force within 24 hours after becoming aware of the theft or loss; and

  • (b) provide a written report to the Minister within 72 hours after becoming aware of the theft or loss and include a confirmation that the report required under paragraph (a) has been provided.

  • SOR/2019-169, s. 3
.

Marginal note:Suspicious transaction

  •  (1) A licensed dealer must provide a written report containing the following information to the Minister within 72 hours after becoming aware of a transaction occurring in the course of their activities that they have reasonable grounds to suspect may be related to the diversion of a narcotic to an illicit market or use:

    • (a) their name, municipal address, telephone number and, if the licensed dealer is a corporation, the position held by the individual making the report;

    • (b) the name and municipal address of the other party to the transaction;

    • (c) details of the transaction, including its date and time, its type, the name and quantity of the narcotic and, in the case of a product or compound, the quantity of every narcotic that it contains;

    • (d) in the case of a product that contains the narcotic, other than a test kit, the drug identification number that is assigned to the product under section C.01.014.2 of the Food and Drug Regulations, if any; and

    • (e) a detailed description of the reasons for those suspicions.

  • Marginal note:Good faith

    (2) No civil proceedings lie against a licensed dealer for having provided the report in good faith.

  • Marginal note:Non-disclosure

    (3) A licensed dealer must not disclose that they have provided the report or disclose details of it, with the intent to prejudice a criminal investigation, whether or not a criminal investigation has begun.

  • SOR/2019-169, s. 3
.

Marginal note:Partial protection against self-incrimination

 A report made under any of sections 27.1 to 27.3, or any evidence derived from it, is not to be used or received to incriminate the licensed dealer in any criminal proceeding against them other than a prosecution under section 132, 136 or 137 of the Criminal Code.

  • SOR/2019-169, s. 3
.

Destruction of Narcotics

Marginal note:Destruction at site

 A licensed dealer that intends to destroy a narcotic at the site specified in their licence must ensure that the following conditions are met:

  • (a) the licensed dealer obtains the prior approval of the Minister;

  • (b) the destruction is carried out in the presence of two of the following persons, at least one of whom must be a person referred to in subparagraph (i):

    • (i) the senior person in charge, the qualified person in charge or an alternate qualified person in charge, and

    • (ii) a person who works for or provides services to the licensed dealer and holds a senior position;

  • (c) the destruction is carried out in accordance with a method that complies with all federal, provincial and municipal environmental protection legislation applicable to the place of destruction; and

  • (d) as soon as the destruction is completed, the person who carried out the destruction and each of the two persons referred to in paragraph (b) who were present at the destruction sign and date a joint declaration attesting that the narcotic was completely destroyed, to which each signatory must add their name in printed letters.

  • SOR/2019-169, s. 3
.

Marginal note:Destruction elsewhere than at site

 A licensed dealer that intends to destroy a narcotic elsewhere than at the site specified in their licence must ensure that the following conditions are met:

  • (a) the licensed dealer obtains the prior approval of the Minister;

  • (b) the licensed dealer takes any measures that are necessary to ensure the security of the narcotic while it is being transported in order to prevent its diversion to an illicit market or use;

  • (c) the destruction is carried out by a person working for a business that specializes in the destruction of dangerous goods and in the presence of another person working for that business;

  • (d) the destruction is carried out in accordance with a method that complies with all federal, provincial and municipal environmental protection legislation applicable to the place of destruction; and

  • (e) as soon as the destruction is completed, the person who carried out the destruction provides the licensed dealer with a dated declaration attesting that the narcotic was completely destroyed and containing

    • (i) the municipal address of the place of destruction,

    • (ii) the name and quantity of the narcotic and, if applicable, the brand name and quantity of the product containing it or the name and quantity of the compound containing it,

    • (iii) the method of destruction,

    • (iv) the date of destruction, and

    • (v) the names in printed letters and signatures of that person and the other person who was present at the destruction.

  • SOR/2019-169, s. 3
.

Marginal note:Application for prior approval

  •  (1) A licensed dealer must submit to the Minister an application that contains the following information in order to obtain the Minister’s prior approval to destroy a narcotic:

    • (a) their name, municipal address and dealer’s licence number;

    • (b) the proposed date of destruction;

    • (c) the municipal address of the place of destruction;

    • (d) a brief description of the method of destruction;

    • (e) if the destruction is to be carried out at the site specified in the dealer’s licence, the names of the persons proposed for the purpose of paragraph 27.5(b) and information establishing that they meet the conditions of that paragraph;

    • (f) the name of the narcotic and, if applicable, the brand name of the product containing it or the name of the compound containing it; and

    • (g) the form and quantity of the narcotic or the product or compound containing it and, if applicable, the strength per unit of the narcotic in the product or compound, the number of units per package and the number of packages.

  • Marginal note:Signature and attestation

    (2) The application must

    • (a) be signed and dated by the qualified person in charge or an alternate qualified person in charge; and

    • (b) include an attestation by that person that

      • (i) the proposed method of destruction complies with all federal, provincial and municipal environmental protection legislation applicable to the place of destruction, and

      • (ii) all of the information submitted in support of the application is correct and complete to the best of the signatory’s knowledge.

  • Marginal note:Additional information and documents

    (3) The licensed dealer must, not later than the date specified in the Minister’s written request to that effect, provide the Minister with any information or document that the Minister determines is necessary to complete the review of the application.

  • SOR/2019-169, s. 3
.

Marginal note:Approval

 On completion of the review of the approval application, the Minister must approve the destruction of the narcotic unless

  • (a) in the case of a destruction that is to be carried out at the site specified in the dealer’s licence, the persons proposed for the purpose of paragraph 27.5(b) do not meet the conditions of that paragraph;

  • (b) the Minister has reasonable grounds to believe that the narcotic would not be destroyed;

  • (c) the Minister has reasonable grounds to believe that the licensed dealer has submitted false or misleading information or false or falsified documents in or in support of the approval application;

  • (d) the narcotic or a portion of it is required for the purposes of a criminal or administrative investigation or a preliminary inquiry, trial or other proceeding under any Act or its regulations; or

  • (e) the Minister has reasonable grounds to believe that the approval would likely create a risk to public health or safety, including the risk of the narcotic being diverted to an illicit market or use.

  • SOR/2019-169, s. 3
.

Documents

Marginal note:Method of recording information

 A licensed dealer must record any information that they are required to record under these Regulations using a method that permits an audit of it to be made at any time.

  • SOR/80-547, s. 1
  • SOR/2004-237, s. 13
  • SOR/2010-221, s. 13
  • SOR/2017-18, s. 24
  • SOR/2019-169, s. 3
.

Marginal note:Information — general

 A licensed dealer must record the following information:

  • (a) the name, form and quantity of any narcotic that the dealer orders, the name of the person who placed the order on the dealer’s behalf and the date of the order;

  • (b) the name, form and quantity of any narcotic that the dealer receives, the name and municipal address of the person who sold or provided it and the date on which it was received;

  • (c) in the case of a narcotic that the dealer sells or provides,

    • (i) the brand name of the product or the name of the compound containing the narcotic and the name of the narcotic,

    • (ii) the drug identification number that has been assigned to the product under section C.01.014.2 of the Food and Drug Regulations, if any,

    • (iii) the form and quantity of the narcotic and, if applicable, the strength per unit of the narcotic in the product or compound, the number of units per package and the number of packages,

    • (iv) the name and municipal address of the person to whom it was sold or provided, and

    • (v) the date on which it was sold or provided;

  • (d) the name, form and quantity of any narcotic that the dealer manufactures or assembles and the date on which it was placed in stock and, if applicable, the strength per unit of the narcotic in the product or compound, the number of units per package and the number of packages;

  • (e) the name and quantity of any narcotic that the dealer uses in the manufacturing or assembling of a product or compound, as well as the brand name and quantity of the product or the name and quantity of the compound, and the date on which the product or compound was placed in stock;

  • (f) the name, form and quantity of any narcotic in stock at the end of each month;

  • (g) the name, form and quantity of any narcotic that the dealer delivers, transports or sends, the name and municipal address of the consignee and the date on which it was delivered, transported or sent;

  • (h) the name, form and quantity of any narcotic that the dealer imports, the date on which it was imported, the name and municipal address of the exporter, the country of exportation and any country of transit or transhipment; and

  • (i) the name, form and quantity of any narcotic that the dealer exports, the date on which it was exported, the name and municipal address of the importer, the country of final destination and any country of transit or transhipment.

  • SOR/2019-169, s. 3
.

Marginal note:Verbal prescription narcotic

 A licensed dealer that receives a verbal order for a verbal prescription narcotic and sells or provides it to a pharmacist, a practitioner or a hospital employee must immediately record

  • (a) the name of the person who placed the order;

  • (b) the date on which the order was received; and

  • (c) the name of the person recording the order.

  • SOR/2019-169, s. 3
.

Marginal note:Explainable loss of narcotic

 A licensed dealer that becomes aware of a loss of a narcotic that can be explained on the basis of normally accepted business activities must record the following information:

  • (a) the name of the lost narcotic and, if applicable, the brand name of the product or the name of the compound containing it;

  • (b) the form and quantity of the narcotic and, if applicable, the form of the product or compound containing it, the strength per unit of the narcotic in the product or compound, the number of units per package and the number of packages;

  • (c) the date on which the dealer became aware of the loss; and

  • (d) the explanation for the loss.

  • SOR/2019-169, s. 3
.

Marginal note:Destruction

 A licensed dealer must record the following information concerning any narcotic that they destroy at the site specified in their licence:

  • (a) the municipal address of the place of destruction;

  • (b) the name, form and quantity of the narcotic and, if applicable, the brand name and quantity of the product containing the narcotic or the name and quantity of the compound containing the narcotic;

  • (c) the method of destruction; and

  • (d) the date of destruction.

  • SOR/2019-169, s. 3
.

Marginal note:Annual report

  •  (1) Subject to subsections (2) and (3), a licensed dealer must provide to the Minister, within three months after the end of each calendar year, an annual report that contains

    • (a) the name, form and total quantity of each narcotic that they receive, produce, sell, provide, import, export or destroy during the calendar year, as well as the name and total quantity of each narcotic that they use to manufacture or assemble a product or compound;

    • (b) the name, form and quantity of each narcotic in physical inventory taken at the site specified in their licence at the end of the calendar year; and

    • (c) the name, form and quantity of any narcotic that has been lost or stolen in the course of conducting activities during the calendar year.

  • Marginal note:Non-renewal or revocation within first three months

    (2) If a licensed dealer’s licence expires without being renewed or is revoked during the first three months of a calendar year, the dealer must provide to the Minister

    • (a) within three months after the end of the preceding calendar year, the annual report in respect of that year; and

    • (b) within three months after the expiry or revocation, a report in respect of the portion of the current calendar year during which the licence was valid that contains the information referred to in subsection (1), in which the quantity in physical inventory is to be calculated as of the date of expiry or revocation.

  • Marginal note:Non-renewal or revocation after third month

    (3) If a licensed dealer’s licence expires without being renewed or is revoked after the first three months of a calendar year, the dealer must provide to the Minister, within three months after the expiry or revocation, a report in respect of the portion of the calendar year during which the licence was valid that contains the information referred to in subsection (1) for that period, in which the quantity in physical inventory is to be calculated as of the date of expiry or revocation.

  • SOR/2019-169, s. 3
.

Marginal note:Retention period

 A licensed dealer and a former licensed dealer must keep any document containing the information that they are required to record under these Regulations, including every declaration and a copy of every report, for a period of two years following the day on which the last record is recorded in the document and in a manner that permits an audit of the document to be made at any time.

  • SOR/2019-169, s. 3
.

Marginal note:Location

 The documents must be kept

  • (a) in the case of a licensed dealer, at the site specified in their licence; and

  • (b) in the case of a former licensed dealer, at a location in Canada.

  • SOR/2019-169, s. 3
.

Marginal note:Quality of documents

 The documents must be complete and readily retrievable and the information in them must be legible and indelible.

  • SOR/2019-169, s. 3
.

Pharmacists

Record of Narcotics Received

Marginal note:General information

 A pharmacist who receives a narcotic from a licensed dealer shall immediately enter the following in a book, register or other record maintained for such purposes:

  • (a) the name and quantity of the narcotic received;

  • (b) the date the narcotic was received; and

  • (c) the name and address of the person from whom the narcotic was received.

  • SOR/85-588, s. 8
  • SOR/2013-119, s. 211
  • SOR/2016-230, s. 267
  • SOR/2018-147, s. 11
.

Sale of Narcotics

Marginal note:Restriction

  •  (1) No pharmacist shall sell or provide narcotics except in accordance with this section and sections 34 to 36 and 45.

  • Marginal note:Exemption or written order or prescription

    (2) A pharmacist may sell or provide a narcotic to a person

    • (a) if the person is exempted under section 56 of the Act with respect to the possession of that narcotic;

    • (b) except in the case of diacetylmorphine (heroin), if the pharmacist has received a written order or prescription for the narcotic that is signed and dated by a practitioner and has verified the signature of the practitioner, if it is not known to them; or

    • (c) in the case of diacetylmorphine (heroin), if the pharmacist has received a written order or prescription for the narcotic that is signed and dated by a practitioner of medicine or a nurse practitioner and has verified the signature of the practitioner, if it is not known to them.

  • (2.1) [Repealed, SOR/2019-169, s. 6]

  • Marginal note:Methadone

    (3) A pharmacist may sell or provide methadone to the following persons, in addition to the persons referred to in subsection (2):

    • (a) a licensed dealer;

    • (b) another pharmacist;

    • (c) a hospital employee; or

    • (d) a practitioner.

  • (4) [Repealed, SOR/2018-147, s. 12]

  • SOR/81-361, s. 2
  • SOR/85-588, s. 9
  • SOR/99-124, s. 4
  • SOR/2004-237, s. 14
  • SOR/2012-230, s. 20
  • SOR/2013-119, s. 212
  • SOR/2014-51, s. 1
  • SOR/2016-230, s. 268
  • SOR/2018-37, s. 4
  • SOR/2018-147, s. 12
  • SOR/2019-169, s. 6
.

Marginal note:Prohibition — pharmacist or practitioner named in notice

 Subject to section 33 and despite subsections 31(2) and (3) and sections 34 to 36, no pharmacist shall

  • (a) sell or provide a narcotic, other than a verbal prescription narcotic, to a pharmacist named in a notice issued by the Minister under paragraph 48(1)(a);

  • (b) sell or provide a verbal prescription narcotic, other than a preparation mentioned in section 36, to a pharmacist named in a notice issued by the Minister under paragraph 48(1)(b);

  • (c) sell or provide a preparation mentioned in section 36 to a pharmacist named in a notice issued by the Minister under paragraph 48(1)(c);

  • (d) dispense, sell or provide a narcotic, other than a verbal prescription narcotic, to a practitioner named in a notice issued by the Minister under subsection 59(1) or fill a prescription or order for a narcotic, other than a verbal prescription narcotic, from a practitioner named in such a notice; or

  • (e) dispense, sell or provide a verbal prescription narcotic to a practitioner named in a notice issued by the Minister under subsection 59(1) or fill a prescription or order for a verbal prescription narcotic from a practitioner named in such a notice.

  • SOR/85-588, s. 10(E)
  • SOR/2003-134, s. 3
  • SOR/2019-169, s. 7
.

Marginal note:Exception — notice of retraction

 Section 32 does not apply to a pharmacist to whom the Minister has issued a notice of retraction of the notice

  • (a) under section 49, in respect of a pharmacist named in a notice issued by the Minister under subsection 48(1); or

  • (b) under section 60, in respect of a practitioner named in a notice issued by the Minister to under subsection 59(1).

  • SOR/2003-134, s. 3
  • SOR/2019-169, s. 8(F)
.

Marginal note:Verbal prescription narcotic

 Subject to section 39, a pharmacist may dispense a verbal prescription narcotic on receipt of a verbal order or prescription given by a person whom the pharmacist has taken reasonable precautions to determine is a practitioner.

  • SOR/85-588, s. 11
  • SOR/85-930, s. 6
  • SOR/2019-169, s. 9
.

Marginal note:Provision to hospital

  •  (1) Subject to subsection (2), a pharmacist may provide a narcotic to an employee of a hospital or a practitioner in a hospital if the pharmacist receives a written order for the narcotic signed and dated by

    • (a) the pharmacist in charge of the hospital’s pharmacy;

    • (b) except in the case of diacetylmorphine (heroin), a practitioner who is authorized by the person in charge of the hospital to sign the order; or

    • (c) in the case of diacetylmorphine (heroin), a practitioner of medicine or dentistry or a nurse practitioner who is authorized by the person in charge of the hospital to sign the order.

  • Marginal note:Signature

    (2) Before providing a narcotic under subsection (1), the pharmacist receiving the order must know the signature on the order or verify it.

  • SOR/85-588, s. 12
  • SOR/99-124, s. 5
  • SOR/2004-237, s. 15
  • SOR/2018-37, s. 5
  • SOR/2019-169, s. 10
.

Marginal note:Low-dose codeine preparation

  •  (1) Subject to subsection (2), a pharmacist may, without a prescription, sell or provide a preparation containing not more than 8 mg or its equivalent of codeine phosphate per tablet or per unit in other solid form or not more than 20 mg or its equivalent of codeine phosphate per 30 mL in a liquid preparation if

    • (a) the preparation contains

      • (i) two additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-half the regular minimum single dose for each such ingredient, or

      • (ii) three additional medicinal ingredients other than a narcotic in a quantity of not less than the regular minimum single dose for one such ingredient or one-third the regular minimum single dose for each such ingredient; and

    • (b) there is legibly and conspicuously printed on the inner label and the outer label, as those terms are defined in section A.01.010 of the Food and Drug Regulations, a caution to the following effect:

      “This preparation contains codeine and should not be administered to children except on the advice of a physician, dentist or nurse practitioner.”

  • Marginal note:Use other than for recognized medical or dental purpose

    (2) No pharmacist shall sell or provide a preparation referred to in subsection (1) if the pharmacist has reasonable grounds to believe that the preparation is to be used for purposes other than recognized medical or dental purposes.

  • SOR/78-154, s. 5
  • SOR/85-588, s. 13
  • SOR/2004-237, s. 16
  • SOR/2012-230, s. 21
.

Marginal note:Maximum Quantity

 A pharmacist must not use an order or prescription to dispense a narcotic after the quantity of the narcotic specified in the order or prescription has been dispensed.

  • SOR/81-361, s. 3
  • SOR/2019-169, s. 11
.

Records

Marginal note:Written order or prescription

 If, in accordance with a written order or prescription, a pharmacist dispenses a narcotic, other than dextropropoxyphene, the pharmacist must immediately enter in a book, register or other record maintained for such purposes

  • (a) their name or initials;

  • (b) the name, initials and municipal address of the practitioner who issued the order or prescription;

  • (c) the name and municipal address of the person named in the order or prescription;

  • (d) the name, form and quantity of the narcotic;

  • (e) the date on which the narcotic was dispensed; and

  • (f) the number assigned to the order or prescription.

  • SOR/82-1073, s. 1
  • SOR/85-588, s. 14(E)
  • SOR/2004-237, s. 17
  • SOR/2019-169, s. 11
.

Marginal note:Verbal order or prescription

 A pharmacist must, before dispensing a verbal prescription narcotic in accordance with a verbal order or prescription, make a written record of it that sets out

  • (a) their name or initials;

  • (b) the name, initials and municipal address of the practitioner who issued the order or prescription;

  • (c) the name and municipal address of the person named in the order or prescription;

  • (d) in accordance with the manner in which it is specified in the order or prescription, the name and quantity of the verbal prescription narcotic or the narcotic and the other medicinal ingredients contained in it;

  • (e) the directions for use given with the order or prescription;

  • (f) the date on which the verbal prescription narcotic was dispensed; and

  • (g) the number assigned to the order or prescription.

  • SOR/85-588, s. 15
  • SOR/2004-237, s. 18
  • SOR/2019-169, s. 11
.

Marginal note:File by date and number

 A pharmacist must maintain a special narcotic prescription file in which are filed, in sequence as to date and number, all written orders and prescriptions for narcotics that they have dispensed and the written record of all verbal prescription narcotics that they have dispensed in accordance with a verbal order or prescription.

  • SOR/85-588, s. 16
  • SOR/2019-169, s. 11
.

Marginal note:Retention period

 A pharmacist must retain in their possession for a period of at least two years any records which they are required to keep by these Regulations.

  • SOR/2019-169, s. 11
.

General Obligations of Pharmacist

Marginal note:Providing information and assisting inspector

 A pharmacist shall

  • (a) furnish such information respecting the dealings of the pharmacist in any narcotic in such form and at such times as the Minister may require;

  • (b) make available and produce to an inspector upon request his special narcotic prescription file together with any books, records or documents which he is required to keep;

  • (c) permit an inspector to make copies of or to take extracts from such files, books, records or documents; and

  • (d) permit an inspector to check all stocks of narcotics on his premises.

Marginal note:Loss or theft — report

 A pharmacist shall report to the Minister any loss or theft of a narcotic within 10 days of his discovery thereof.

Marginal note:Loss or theft — protective measures

 A pharmacist shall take all reasonable steps that are necessary to protect narcotics on his premises or under his control against loss or theft.

  • SOR/81-361, s. 4
  • SOR/85-588, s. 17
.

Marginal note:Preparing narcotic – approval of formula

  •  (1) No pharmacist shall prepare a narcotic unless the Minister has approved the formula thereof, and if such narcotic is a preparation described in section 36, has approved the label and the size of the container in which it will be sold.

  • Marginal note:Record — preparation

    (2) A pharmacist who prepares a narcotic shall, in addition to all other records required to be kept, keep a record of the following:

    • (a) the kind and quantity of any narcotic used in the preparation;

    • (b) the name and quantity of the narcotic prepared; and

    • (c) the date that the prepared narcotic was placed in stock.

  • Marginal note:Definition of prepare

    (3) For the purposes of this section, “prepare” does not include the compounding of a narcotic pursuant to a prescription of a practitioner.

Return or Emergency Sale

Marginal note:Written order

  •  (1) A pharmacist may, on receiving a written order for a narcotic

    • (a) return the narcotic to the licensed dealer who sold or provided it to the pharmacist, if the order is signed and dated by the licensed dealer; or

    • (b) sell or provide to another pharmacist the quantity of the narcotic that is specified in the order as being required for emergency purposes, if the order is signed and dated by the other pharmacist.

  • Marginal note:Record

    (2) A pharmacist shall, immediately after returning, selling or providing a narcotic under subsection (1) or after receiving a narcotic under paragraph (1)(b) or subsection 65(4), enter the details of the transaction in a book, register or other record maintained for the purpose of recording such transactions.

  • Marginal note:Notice to Minister

    (3) A pharmacist shall forthwith after removing, transporting or transferring a narcotic from his place of business to any other place of business operated by him notify the Minister setting out the details thereof.

  • SOR/81-361, s. 5
  • SOR/85-588, s. 18
  • SOR/2004-237, s. 19
  • SOR/2013-119, s. 213(E)
  • SOR/2014-260, s. 24(E)
.

Communication of Information by Minister to Licensing Authority

Marginal note:Contraventions by pharmacist

 The Minister must provide in writing any factual information about a pharmacist that has been obtained under the Act or these Regulations to the provincial professional licensing authority that is responsible for the authorization of the person to practise their profession

  • (a) in the province in which the pharmacist is or was entitled to practise if

    • (i) the authority submits to the Minister a written request that sets out the pharmacist’s name and address, a description of the information being requested and a statement that the information is required for the purpose of assisting a lawful investigation by the authority, or

    • (ii) the Minister has reasonable grounds to believe that the pharmacist has

      • (A) contravened a rule of conduct established by the authority,

      • (B) been convicted of a designated substance offence, or

      • (C) contravened these Regulations; or

  • (b) in a province in which the pharmacist is not entitled to practise, if the authority submits to the Minister

    • (i) a written request that sets out the pharmacist’s name and address and a description of the information being requested, and

    • (ii) a document that shows that

      • (A) the pharmacist has applied to that authority to practise in that province, or

      • (B) the authority has reasonable grounds to believe that the pharmacist is practising in that province without being authorized to do so.

  • SOR/86-882, s. 1
  • SOR/2003-134, s. 4
  • SOR/2010-221, s. 17
  • SOR/2013-119, s. 214
  • SOR/2016-230, s. 278
  • SOR/2018-147, s. 13
  • SOR/2019-169, s. 14
.

Notice of Prohibition of Sale

Marginal note:Request by pharmacist

 A pharmacist may make a written request to the Minister to send to the persons and authorities specified in subsection 48(3) a notice, issued under section 48, advising them of one or more of the following requirements:

  • (a) recipients of the notice must not sell or provide a narcotic, other than a verbal prescription narcotic, to that pharmacist;

  • (b) recipients of the notice must not sell or provide a verbal prescription narcotic, other than a preparation mentioned in section 36, to that pharmacist; and

  • (c) the recipients of the notice must not sell or provide a preparation mentioned in section 36 to that pharmacist.

  • SOR/2003-134, s. 4
.

Marginal note:Notice by Minister

  •  (1) In the circumstances described in subsection (2), the Minister must send a notice to the persons and authorities specified in subsection (3) advising them that pharmacists practising in the notified pharmacies and licensed dealers must not sell or provide to the pharmacist named in the notice one or more of the following:

    • (a) a narcotic, other than a verbal prescription narcotic;

    • (b) a verbal prescription narcotic, other than a preparation mentioned in section 36; or

    • (c) a preparation mentioned in section 36.

  • Marginal note:Circumstances requiring a notice

    (2) The notice must be sent if the pharmacist named in the notice has

    • (a) made a request to the Minister in accordance with section 47 to send the notice;

    • (b) contravened a rule of conduct established by the provincial professional licensing authority of the province in which the pharmacist is practising and the authority has requested the Minister in writing to send the notice; or

    • (c) been convicted of a designated substance offence or of a contravention of these Regulations.

  • Marginal note:Recipients

    (3) The notice must be sent to

    • (a) all licensed dealers;

    • (b) all pharmacies within the province in which the pharmacist named in the notice is entitled to practice and is practising;

    • (c) the provincial professional licensing authority of the province in which the pharmacist named in the notice is entitled to practise;

    • (d) all pharmacies in an adjacent province in which an order from the pharmacist named in the notice may be filled; and

    • (e) any provincial professional licensing authority in another province that has requested the Minister in writing to send the notice.

  • Marginal note:Other circumstances

    (4) The Minister may send the notice described in subsection (1) to the persons and authorities specified in subsection (3) if the Minister has taken the measures specified in subsection (5) and has reasonable grounds to believe that the pharmacist named in the notice

    • (a) has contravened a provision of the Act or these Regulations;

    • (b) has, on more than one occasion, self-administered a narcotic, other than a verbal prescription narcotic, contrary to accepted pharmaceutical practice;

    • (c) has, on more than one occasion, self-administered a verbal prescription narcotic, other than a preparation mentioned in section 36, contrary to accepted pharmaceutical practice;

    • (d) has, on more than one occasion, provided or administered a narcotic, other than a verbal prescription narcotic, to a person who is a spouse, common-law partner, parent or child of the pharmacist, including a child adopted in fact, contrary to accepted pharmaceutical practice;

    • (e) has, on more than one occasion, provided or administered a verbal prescription narcotic, other than a preparation mentioned in section 36, to a person who is a spouse, common-law partner, parent or child of the pharmacist, including a child adopted in fact, contrary to accepted pharmaceutical practice; or

    • (f) is unable to account for the quantity of narcotic for which the pharmacist was responsible under these Regulations.

  • Marginal note:Measures before sending notice

    (5) The measures that must be taken before sending the notice are that the Minister has

    • (a) consulted with the provincial professional licensing authority of the province in which the pharmacist to whom the notice relates is entitled to practise;

    • (b) given that pharmacist an opportunity to be heard; and

    • (c) considered

      • (i) the compliance history of the pharmacist in respect of the Act and its regulations, and

      • (ii) whether the actions of the pharmacist pose a risk to public health or safety, including the risk of the narcotic being diverted to an illicit market or use.

  • SOR/2003-134, s. 4
  • SOR/2010-221, ss. 17, 18(F)
  • SOR/2013-119, s. 215
  • SOR/2016-230, s. 278
  • SOR/2018-147, s. 14
  • SOR/2019-169, s. 15
.

Marginal note:Notice of retraction

 The Minister must provide the licensed dealers, pharmacies and provincial professional licensing authorities who were sent a notice under subsection 48(1) with a notice of retraction of that notice if

  • (a) in the circumstance described in paragraph 48(2)(a), the requirements set out in subparagraphs (b)(i) and (ii) have been met and one year has elapsed since the notice was sent by the Minister; or

  • (b) in a circumstance described in any of paragraphs 48(2)(b) and (c) and (4)(a) to (f), the pharmacist named in the notice has

    • (i) requested in writing that a retraction of the notice besent, and

    • (ii) provided a letter from the provincial professional licensing authority of the province, in which the pharmacist is entitled to practise, in which the authority consents to the retraction of the notice.

  • SOR/2003-134, s. 4
  • SOR/2010-221, s. 17
  • SOR/2013-119, s. 216
  • SOR/2018-147, s. 15
  • SOR/2019-169, s. 15
.

 [Repealed, SOR/2003-134, s. 4]

Practitioners

Administer, Prescribe or Sell Narcotics

Marginal note:Restriction

  •  (1) No practitioner shall administer a narcotic to a person or animal, or prescribe, sell or provide a narcotic for a person or animal, except as authorized under this section.

  • Marginal note:Conditions

    (2) Subject to subsection (4), a practitioner may administer a narcotic to a person or animal, or prescribe, sell or provide it for a person or animal, if

    • (a) the person or animal is a patient under their professional treatment; and

    • (b) the narcotic is required for the condition for which the person or animal is receiving treatment.

  • (3) [Repealed, SOR/2018-37, s. 6]

  • Marginal note:Heroin

    (4) A practitioner of dentistry or veterinary medicine shall not administer diacetylmorphine (heroin) to an animal or to a person who is not an in-patient or out-patient of a hospital providing care or treatment to persons, and shall not prescribe, sell or provide diacetylmorphine (heroin) for an animal or such a person.

  • (5) [Repealed, SOR/2018-147, s. 16]

  • SOR/85-930, s. 7
  • SOR/99-124, s. 6
  • SOR/2001-227, s. 71
  • SOR/2004-237, s. 20
  • SOR/2012-230, s. 22
  • SOR/2013-119, s. 217
  • SOR/2013-172, s. 7
  • SOR/2016-230, ss. 269, 278
  • SOR/2016-239, s. 6
  • SOR/2018-37, s. 6
  • SOR/2018-147, s. 16
.

Marginal note:Record of narcotics sold or provided

  •  (1) A practitioner who sells or provides a narcotic to a person for self-administration or for administration to an animal shall, whether or not the practitioner charges for the narcotic, keep a record showing the name and quantity of the narcotic sold or provided, the name and address of the person to whom it was sold or provided and the date on which it was sold or provided, if the quantity of the narcotic exceeds

    • (a) three times the maximum daily dosage recommended by the manufacturer or assembler of the narcotic for that narcotic; or

    • (b) three times the generally recognized maximum daily therapeutic dosage for the narcotic if the manufacturer or assembler has not recommended a maximum daily dosage.

  • Marginal note:Accessibility of record

    (2) The practitioner shall keep the record in a place, form and manner that will permit an inspector readily to examine and obtain information from it.

  • SOR/2004-237, s. 21
  • SOR/2013-119, s. 218
  • SOR/2016-230, s. 270
  • SOR/2018-147, s. 17
  • SOR/2019-169, s. 17
.

General Obligations of Practitioner

Marginal note:Requirements

 A practitioner shall

  • (a) furnish to the Minister any information that the Minister may require respecting

    • (i) the use by the practitioner of narcotics received — including the administering, selling or providing of them to a person,

    • (ii) the prescriptions for narcotics issued by the practitioner; and

    • (iii) [Repealed, SOR/2018-147, s. 18]

  • (b) produce to an inspector on request any records that these Regulations require the practitioner to keep;

  • (c) permit an inspector to make copies of such records or to take extracts therefrom;

  • (d) permit an inspector to check all stocks of narcotics on the practitioner’s premises;

  • (e) retain in his possession for at least two years any record that these Regulations require him to keep;

  • (f) take adequate steps to protect narcotics in his possession from loss or theft; and

  • (g) report to the Minister any loss or theft of a narcotic within 10 days of the practitioner’s discovery of the loss or theft.

  • SOR/2004-237, s. 22
  • SOR/2013-119, s. 219
  • SOR/2016-230, s. 271
  • SOR/2018-147, s. 18
.

 [Repealed, SOR/2010-221, s. 14]

Communication of Information by Minister to Licensing Authority

Marginal note:Contraventions by practitioner

 The Minister must provide in writing any factual information about a practitioner that has been obtained under the Act or these Regulations to the provincial professional licensing authority that is responsible for the registration and authorization of the person to practise their profession

  • (a) in the province in which the practitioner is or was registered and entitled to practise if

    • (i) the authority submits to the Minister a written request that sets out the practitioner’s name and address, a description of the information being requested and a statement that the information is required for the purpose of assisting a lawful investigation by the authority, or

    • (ii) the Minister has reasonable grounds to believe that the practitioner has

      • (A) contravened a rule of conduct established by the authority,

      • (B) been convicted of a designated substance offence, or

      • (C) contravened these Regulations; or

  • (b) in a province in which the practitioner is not registered and entitled to practise, if the authority submits to the Minister

    • (i) a written request that sets out the practitioner’s name and address and a description of the information being requested, and

    • (ii) a document that shows that

      • (A) the practitioner has applied to that authority to practise in that province, or

      • (B) the authority has reasonable grounds to believe that the practitioner is practising in that province without being authorized to do so.

  • SOR/86-882, s. 2
  • SOR/2003-134, s. 5
  • SOR/2010-221, s. 17
  • SOR/2013-119, s. 220
  • SOR/2015-132, s. 2
  • SOR/2016-230, s. 272
  • SOR/2018-147, s. 19
  • SOR/2019-169, s. 19
.

Notice of Prohibition of Sale

Marginal note:Request by practitioner

 A practitioner may make a written request to the Minister to send to licensed dealers and pharmacies a notice, issued under section 59, advising them of one or more of the following requirements:

  • (a) recipients of the notice must not sell or provide a narcotic, other than a verbal prescription narcotic, to that practitioner;

  • (b) recipients of the notice must not sell or provide a verbal prescription narcotic to the practitioner;

  • (c) pharmacists practising in the notified pharmacies must not fill a prescription or order for a narcotic, other than a verbal prescription narcotic, written by that practitioner; or

  • (d) pharmacists practising in the notified pharmacies must not fill a prescription or order for a verbal prescription narcotic from that practitioner.

  • (e) [Repealed, SOR/2018-147, s. 20]

  • (f) and (g) [Repealed, SOR/2013-119, s. 221]

  • SOR/2003-134, s. 5
  • SOR/2013-119, s. 221
  • SOR/2016-230, s. 273
  • SOR/2018-147, s. 20
.

Marginal note:Notice by Minister

  •  (1) In the circumstances described in subsection (2), the Minister must send a notice to the persons and authorities specified in subsection (3) advising them that

    • (a) pharmacists practising in the notified pharmacies and licensed dealers must not sell or provide to the practitioner named in the notice a narcotic other than a verbal prescription narcotic or a verbal prescription narcotic;

    • (b) pharmacists practising in the notified pharmacies must not fill a prescription or order from the practitioner named in the notice for a narcotic other than a verbal prescription narcotic or a verbal prescription narcotic; or

    • (c) the prohibitions in both paragraphs (a) and (b) apply with respect to the practitioner named in the notice.

  • Marginal note:Circumstances requiring a notice

    (2) The notice must be sent if the practitioner named in the notice has

    • (a) made a request to the Minister in accordance with section 58 to send the notice;

    • (b) contravened a rule of conduct established by the provincial professional licensing authority of the province in which the practitioner is practising and the authority has requested the Minister in writing to send the notice; or

    • (c) been convicted of a designated substance offence or of a contravention of these Regulations.

  • Marginal note:Recipients

    (3) The notice must be sent to

    • (a) all licensed dealers;

    • (b) all pharmacies within the province in which the practitioner named in the notice is registered and entitled to practise and is practising;

    • (c) the provincial professional licensing authority of the province in which the practitioner named in the notice is registered and entitled to practise;

    • (d) all pharmacies in an adjacent province in which a prescription or order from the practitioner named in the notice may be filled; and

    • (e) any provincial professional licensing authority in another province that has requested the Minister in writing to send the notice.

  • Marginal note:Other circumstances

    (4) The Minister may send the notice described in subsection (1) to the persons and authorities specified in subsection (3) if the Minister has taken the measures specified in subsection (5) and has reasonable grounds to believe that the practitioner named in the notice

    • (a) has contravened a provision of the Act or these Regulations;

    • (b) has, on more than one occasion, self-administered a narcotic, other than a verbal prescription narcotic, under a self-directed prescription or order or, in the absence of a prescription or order, contrary to accepted professional practice;

    • (c) has, on more than one occasion, self-administered a verbal prescription narcotic under a self-directed prescription or order or, in the absence of a prescription or order, contrary to accepted professional practice;

    • (d) has, on more than one occasion, prescribed, provided or administered a narcotic, other than a verbal prescription narcotic, to a person who is a spouse, common-law partner, parent or child of the practitioner, including a child adopted in fact, contrary to accepted professional practice;

    • (e) has, on more than one occasion, prescribed, provided or administered a verbal prescription narcotic to a person who is a spouse, common-law partner, parent or child of the practitioner, including a child adopted in fact, contrary to accepted professional practice; or

    • (f) is unable to account for the quantity of narcotic for which the practitioner was responsible under these Regulations.

  • Marginal note:Measures before sending notice

    (5) The measures that must be taken before sending the notice are that the Minister has

    • (a) consulted with the provincial professional licensing authority of the province in which the practitioner to whom the notice relates is registered and entitled to practise;

    • (b) given that practitioner an opportunity to be heard; and

    • (c) considered

      • (i) the compliance history of the practitioner in respect of the Act and its regulations, and

      • (ii) whether the actions of the practitioner pose a risk to public health or safety, including the risk of the narcotic being diverted to an illicit market or use.

  • SOR/2003-134, s. 5
  • SOR/2010-221, ss. 17, 18(F)
  • SOR/2013-119, s. 222
  • SOR/2016-230, ss. 274, 278
  • SOR/2017-18, s. 25
  • SOR/2018-147, s. 21
  • SOR/2019-169, s. 20
.

Marginal note:Notice of retraction

 The Minister must provide the licensed dealers, pharmacies and provincial professional licensing authorities who were sent a notice under subsection 59(1) with a notice of retraction of that notice if

  • (a) in the circumstance described in paragraph 59(2)(a), the requirements set out in subparagraphs (b)(i) and (ii) have been met and one year has elapsed since the notice was sent by the Minister; or

  • (b) in a circumstance described in any of paragraphs 59(2)(b) and (c) and (4)(a) to (f), the practitioner named in the notice has

    • (i) requested in writing that a retraction of the notice be sent, and

    • (ii) provided a letter from the provincial professional licensing authority of the province in which the practitioner is registered and entitled to practise in which the authority consents to the retraction of the notice.

  • SOR/85-588, s. 20(E)
  • SOR/2003-134, s. 5
  • SOR/2010-221, s. 17
  • SOR/2013-119, s. 223
  • SOR/2018-147, s. 22
  • SOR/2019-169, s. 20
.

Hospitals

Marginal note:General obligations

 A person who is in charge of a hospital shall

  • (a) keep or cause to be kept in a book, register or other record maintained for such purposes,

    • (i) the name and quantity of any narcotic received,

    • (ii) the name and address of the person from whom any narcotic was received and the date received,

    • (iii) the name and quantity of any narcotic used in the making or assembling of a product or compound containing that narcotic,

    • (iv) the name and quantity of any product or compound that was made or assembled and that contains that narcotic and the date on which the product or compound was made or assembled,

    • (v) the name of the patient for whom a narcotic, other than dextropropoxyphene or a verbal prescription narcotic, was dispensed,

    • (vi) the name of the practitioner ordering or prescribing a narcotic, other than dextropropoxyphene or a verbal prescription narcotic, and

    • (vii) the date a narcotic, other than dextropropoxyphene or a verbal prescription narcotic was ordered or prescribed and the form and quantity thereof;

    • (viii) to (x) [Repealed, SOR/2018-147, s. 23]

  • (b) maintain the recorded information in such form as to enable an audit to be made from time to time for a period of not less than two years from the making thereof;

  • (c) take all necessary steps to protect narcotics in the hospital against loss or theft, and report to the Minister any loss or theft of narcotics within 10 days of his discovery thereof.

  • SOR/82-1073, s. 2
  • SOR/85-588, s. 21(E)
  • SOR/2004-237, s. 24
  • SOR/2013-119, s. 224
  • SOR/2016-230, s. 275
  • SOR/2018-147, s. 23
  • SOR/2019-169, s. 21(F)
.

Marginal note:Providing information and assisting inspector

 A person who is in charge of a hospital shall

  • (a) furnish such information respecting the use of narcotics therein, in such form and at such times as the Minister may require;

  • (b) produce to an inspector any books, records or documents required by these Regulations to be kept;

  • (c) permit an inspector to make copies thereof or take extracts from such books, records and documents; and

  • (d) permit an inspector to check all stocks of narcotics in the hospital.

  • SOR/2019-169, s. 22(F)
.

Marginal note:Selling, providing or administering narcotic

  •  (1) No person in charge of a hospital shall permit a narcotic to be sold, provided or administered except in accordance with this section.

  • Marginal note:Written order or prescription

    (2) On receipt of a written order or prescription signed and dated by a practitioner, the person in charge of a hospital may permit a narcotic, other than diacetylmorphine (heroin), to be administered to a person or an animal under treatment as an in-patient or out-patient of the hospital, or to be sold or provided for the person or to the person in charge of the animal.

  • Marginal note:Verbal prescription narcotic

    (2.1) On receipt of a verbal prescription given by a practitioner, the person in charge of a hospital may permit a verbal prescription narcotic to be administered to a person or an animal under treatment as an in-patient or out-patient of the hospital, or to be sold or provided for the person or to the person in charge of the animal.

  • Marginal note:Emergency — other hospital

    (3) Subject to subsection (5.1), the person in charge of a hospital may permit a narcotic to be provided, for emergency purposes, to a hospital employee or practitioner in another hospital on receipt of a written order signed and dated by a pharmacist in the other hospital or a practitioner authorized by the person in charge of the other hospital to sign the order.

  • (3.1) [Repealed, SOR/2018-147, s. 24]

  • Marginal note:Emergency — pharmacist

    (4) Subject to subsection (5.1), the person in charge of a hospital may permit a narcotic to be sold or provided, for emergency purposes, to a pharmacist on receipt of a written order signed and dated by the pharmacist.

  • (5) [Repealed, SOR/2018-37, s. 7]

  • Marginal note:Signature

    (5.1) No person in charge of a hospital shall permit a narcotic to be sold or provided under subsection (3) or (4) unless the signature of the pharmacist in the other hospital or of the practitioner authorized by the person in charge of the other hospital to sign an order is known to the person who sells or provides the narcotic or has been verified.

  • (5.2) [Repealed, SOR/2018-147, s. 24]

  • Marginal note:Research purposes

    (6) A person in charge of a hospital may permit a narcotic to be provided to a person who is exempted under section 56 of the Act with respect to the possession of the narcotic and who is employed in a research laboratory in the hospital for the purpose of research.

  • Marginal note:Heroin

    (7) The person in charge of a hospital may permit diacetylmorphine (heroin) to be sold, provided or administered to a person under treatment as an in-patient or out-patient of the hospital on receipt of a written order or prescription signed and dated by a practitioner of medicine or dentistry or a nurse practitioner.

  • SOR/85-588, s. 22
  • SOR/85-930, s. 8
  • SOR/88-279, s. 2(F)
  • SOR/99-124, s. 7
  • SOR/2004-237, s. 25
  • SOR/2012-230, s. 23
  • SOR/2013-119, s. 225
  • SOR/2013-172, s. 8
  • SOR/2014-51, s. 2
  • SOR/2016-230, s. 276
  • SOR/2016-239, s. 7
  • SOR/2018-37, s. 7
  • SOR/2018-147, s. 24
  • SOR/2019-169, s. 23
.

 [Repealed, SOR/2018-147, s. 25]

 [Repealed, SOR/2018-147, s. 25]

 [Repealed, SOR/2018-147, s. 25]

General

 [Repealed, SOR/97-227, s. 3]

Marginal note:Opium poppy

 The Minister may, on application for it, issue a licence to any person who, in the opinion of the Minister, is qualified to produce opium poppy for scientific purposes, on any terms and conditions that the Minister considers necessary.

  • SOR/2013-119, s. 227(E)
  • SOR/2016-123, s. 2(F)
  • SOR/2018-147, s. 26
.

Marginal note:Identification or analysis of narcotic

  •  (1) Despite anything in these Regulations, a person may, for the purpose of identification or analysis of a narcotic, provide or deliver it to

    • (a) a practitioner of medicine; or

    • (b) an agent or mandatary of a practitioner of medicine, if the agent or mandatary is exempted under section 56 of the Act with respect to the possession of that narcotic for that purpose.

  • Marginal note:Agent or mandatary of practitioner of medicine

    (2) An agent or mandatary of a practitioner of medicine who receives the narcotic must immediately provide or deliver it to

    • (a) the practitioner; or

    • (b) the Minister.

  • Marginal note:Practitioner of medicine

    (3) A practitioner of medicine who receives the narcotic must immediately provide or deliver it

    • (a) for the purpose of its identification or analysis, to a person who is exempted under section 56 of the Act with respect to the possession of that narcotic for that purpose; or

    • (b) to the Minister.

  • SOR/85-930, s. 9
  • SOR/99-124, s. 8
  • SOR/2004-237, s. 26
  • SOR/2018-69, ss. 75, 77
  • SOR/2019-169, s. 24
.

Marginal note:Records — person who is exempted or who has received a narcotic for the purpose of identification or analysis

 Every person who is exempted under section 56 of the Act with respect to the possession of a narcotic — other than a person to whom a narcotic has been administered, sold, delivered or provided by a practitioner of medicine who is exempted under section 56 of the Act from the application of any subsection of section 53 with respect to that narcotic —, every practitioner of medicine who has received a narcotic under subsection 68(1) or (2) and every agent or mandatary of a practitioner of medicine who has received a narcotic under subsection 68(1) must

  • (a) keep a record of the following information for a two-year period beginning on the day on which the record is made

    • (i) the name and quantity of any narcotic purchased or received by them and the date on which it was purchased or received,

    • (ii) the name and address of the person from whom the narcotic was purchased or received, and

    • (iii) particulars of the use to which the narcotic was put;

  • (b) provide any information respecting the narcotic that the Minister may require; and

  • (c) permit access to the records that are required to be kept by these Regulations.

  • SOR/85-588, s. 23
  • SOR/99-124, s. 9
  • SOR/2004-237, s. 27
  • SOR/2010-221, s. 15
  • SOR/2018-69, s. 75
  • SOR/2019-169, s. 24
.

Marginal note:Advertising

 It is prohibited to

  • (a) advertise a narcotic to the general public;

  • (b) advertise a preparation referred to in section 36 in a pharmacy; or

  • (c) publish any written advertisement respecting a narcotic unless that advertisement displays the symbol “N” in a clear and conspicuous colour and size in the upper left quarter of its first page.

  • SOR/2019-169, s. 24
.

 [Repealed, SOR/2019-169, s. 25]

Marginal note:Notification of application for order of restoration

  •  (1) For the purpose of subsection 24(1) of the Act, notification of an application for an order of restoration must be given in writing to the Attorney General by registered mail and be mailed at least 15 days before the date on which the application is to be made to a justice.

  • Marginal note:Content of notice

    (2) The notification must specify

    • (a) the name of the justice to whom the application is to be made;

    • (b) the time and place at which the application is to be heard;

    • (c) details concerning the narcotic or other thing in respect of which the application is to be made; and

    • (d) the evidence on which the applicant intends to rely to establish that they are entitled to possession of the narcotic or other thing referred to in paragraph (c).

  • SOR/97-227, s. 4
  • SOR/2019-169, s. 26
.

Marginal note:Communication of information by Minister to nursing statutory body

  •  (1) The Minister may provide to a nursing statutory body any information concerning any member of that body that has been obtained under these Regulations or the Act.

  • Marginal note:Non-application

    (2) Subsection (1) does not apply to a nurse practitioner.

  • Marginal note:Definitions

    (3) The following definitions apply in this section.

    member

    member means any person who is authorized by a nursing statutory body to practice nursing. (membre)

    nursing statutory body

    nursing statutory body means any provincial professional licensing authority that, in accordance with the laws of that province, authorizes a person to practise nursing. (organisme régissant la profession d’infirmier)

  • SOR/82-121, s. 1
  • SOR/2010-221, s. 16
  • SOR/2012-230, s. 24
  • SOR/2013-119, s. 228
  • SOR/2016-230, s. 278
  • SOR/2018-147, s. 27
  • SOR/2019-169, s. 27
.

Marginal note:Exemption — member of police force

 A member of a police force or a person acting under their direction and control who, in respect of the conduct of the member or person, is exempt from the application of subsection 4(2) or section 5, 6 or 7 of the Act by virtue of the Controlled Drugs and Substances Act (Police Enforcement) Regulations is, in respect of that conduct, exempt from the application of these Regulations.

  • SOR/97-227, s. 5
  • SOR/2019-169, s. 27
.
Loading…